AF
ONC

Avanza Fonder’s BeOne Medicines Ltd ONC Stock Holding History

Avanza Fonder’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,408
Closed -$428K – 513
2025
Q4 		$428K Buy
1,408
+340
+32% +$111K 0.01% 404
2025
Q3 		$364K Buy
1,068
+245
+30% +$74.4K 0.01% 372
2025
Q2 		$199K Sell
823
-84
-9% -$20.6K 0.01% 388
2025
Q1 		$249K Buy
907
+232
+34% +$54.2K 0.01% 406
2024
Q4 		$125K Buy
+675
New +$138K ﹤0.01% 416

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Avanza Fonder's ONC Position: Q1 2026 in Review

Avanza Fonder sold out of BeOne Medicines Ltd (ONC) in Q1 2026, closing a stake of 1,408 shares — an estimated $428K sold.

Avanza Fonder first reported a position in ONC in Q4 2024 and held it in 5 quarters. The position peaked at $428K in Q4 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Avanza Fonder reported no remaining BeOne Medicines Ltd position as of Q1 2026 after selling out during the quarter.
  • Avanza Fonder sold 1,408 BeOne Medicines Ltd shares in Q1 2026, an estimated $428K.
  • Avanza Fonder first reported a position in BeOne Medicines Ltd in Q4 2024 and held it in 5 quarters.
  • Avanza Fonder's BeOne Medicines Ltd position peaked at $428K in Q4 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Avanza Fonder's 13F filing for Q1 2026, filed 15 Apr 2026.